Pinnacle Wealth Planning Services’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
Other funds holding LFCR
WC
LPAM
GRIM
3C
QOP
Pinnacle Wealth Planning Services's LFCR Position: Q2 2026 in Review
Pinnacle Wealth Planning Services held its Lifecore Biomedical (LFCR) position steady in Q2 2026 at 7,355 shares worth $38.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1452.
Pinnacle Wealth Planning Services first reported a position in LFCR in Q1 2023 and has held it in 10 quarters since. The position peaked at $182K in Q2 2023. 99 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.
- Pinnacle Wealth Planning Services held 7,355 shares of Lifecore Biomedical worth $38.6K as of Q2 2026.
- Pinnacle Wealth Planning Services left its Lifecore Biomedical share count unchanged in Q2 2026.
- Lifecore Biomedical made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #1452 holding.
- Pinnacle Wealth Planning Services first reported a position in Lifecore Biomedical in Q1 2023 and has held it in 10 quarters since.
- Pinnacle Wealth Planning Services's Lifecore Biomedical position peaked at $182K in Q2 2023.
- 99 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.
Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.